Celecoxib clinical trials
Also written Celebrex, SC-58635, YM 177 and Onsenal.
How each study uses Celecoxib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Celecoxib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 31 Dec 1998 · CELEBREX · NDA 020998 (FDA, Drugs@FDA)
- European Union
- 17 Oct 2003 · Onsenal · EMEA/H/C/000466 (EMA; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
375 studies that test it; most in 2003 (46); 2 more planned to start later
| Year | Studies |
|---|---|
| 1998 | 2 |
| 1999 | 3 |
| 2000 | 9 |
| 2001 | 15 |
| 2002 | 27 |
| 2003 | 46 |
| 2004 | 29 |
| 2005 | 19 |
| 2006 | 20 |
| 2007 | 10 |
| 2008 | 15 |
| 2009 | 13 |
| 2010 | 9 |
| 2011 | 9 |
| 2012 | 7 |
| 2013 | 7 |
| 2014 | 13 |
| 2015 | 10 |
| 2016 | 16 |
| 2017 | 10 |
| 2018 | 15 |
| 2019 | 19 |
| 2020 | 8 |
| 2021 | 7 |
| 2022 | 9 |
| 2023 | 5 |
| 2024 | 9 |
| 2025 | 7 |
| 2026 | 7 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 72 · Other 311
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (32) · National Cancer Institute (NCI) (13) · Pfizer (10) · Roswell Park Cancer Institute (7) · M.D. Anderson Cancer Center (7) · Cairo University (7) · Dana-Farber Cancer Institute (7) · University of Alabama at Birmingham (6)
Often tested with
Tested in the same studies.
Acetaminophen (19) · Gabapentin (14) · Cyclophosphamide (14) · Naproxen (11) · Capecitabine (11) · Tramadol (9) · Ketorolac (8) · Pregabalin (8)
Related medicines
As reviewed, each with the page that says it.
- One of Anti-Inflammatory Agents, Non-Steroidal source
- One of COX-2 inhibitors source
- One of NSAIDs source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 6
Studies that test Celecoxib.
- Nov 2026Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver CancerPhase 2 · Emory University
- Nov 2026Celecoxib in Parkinson Disease as Adjuvant TherapyPhase 1/2 · Tanta University
- Jan 2027Impact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic SurgeriesPhase 4 · Northwell Health
- Jul 2027Effects and Mechanisms of Celecoxib on Intracerebral HemorrhagePhase 2 · National Taiwan University Hospital
- Sep 2027Celecoxib for ENT Pain ManagementPhase 2 · University of Wisconsin, Madison
- Sep 2027TriGlytza®-01 Versus Metformin in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin TherapyPhase 2 · Myopharm Limited
Studies
Open first, then newest update. How each study uses Celecoxib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 383
- SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID DysfunctionRecruitingPhase 2Icahn School of Medicine at Mount SinaiNCT07597902Written as Celecoxib
- Ivarmacitinib With or Without Celecoxib for Ankylosing SpondylitisNot yet recruitingPhase 4Peking University Third HospitalNCT07894497Written as Ivarmacitinib with celecoxib
- Preoperative Celecoxib and Acetaminophen Versus Acetaminophen Alone for Pain Control After Pediatric AdenotonsillectomyNot yet recruitingPhase 1/2NYU Langone HealthNCT07870447Written as Celecoxib
- Impact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic SurgeriesRecruitingPhase 4Northwell HealthNCT06379425Written as Celecoxib
- Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States PopulationRecruitingPhase 2Mayo ClinicNCT06997068Written as Celecoxib
- A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic CholangiocarcinomaNot yet recruitingPhase 1/2Shanghai 6th People's HospitalNCT07632235Written as Celecoxib + Pembrolizumab + Gemcitabine/Cisplatin
- Celecoxib for ENT Pain ManagementRecruitingPhase 2University of Wisconsin, MadisonNCT06505187Written as Celecoxib
- Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCLRecruitingPhase 2Sun Yat-sen UniversityNCT07494565Written as Celecoxib Combined with R-CHOP
- TriGlytza®-01 Versus Metformin in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin TherapyNot yet recruitingPhase 2Myopharm LimitedNCT07139405Written as Celecoxib
- Timed Aspirin Chronobiome StudyNot yet recruitingEarly Phase 1University of PennsylvaniaNCT03590821Written as Celecoxib 200mg capsule
- Toripalimab Plus Celecoxib for dMMR/MSI-H Locally Advanced Colorectal CancerRecruitingPhase 2Sun Yat-sen UniversityNCT06903858Written as Toripalimab plus celecoxib
- Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee OsteoarthritisRecruitingPhase 4Northwestern UniversityNCT06245109Written as Celecoxib
- Stony Brook Medicine Anti-Inflammatory TrialNot yet recruitingPhase 4Stony Brook UniversityNCT06699966Written as Celecoxib
- Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver CancerRecruitingPhase 2Emory UniversityNCT07174570Written as Celecoxib
- Celecoxib in Parkinson Disease as Adjuvant TherapyRecruitingPhase 1/2Tanta UniversityNCT07246278Written as Celecoxib 200mg
- Triple Negative Breast Cancer and Celecoxib. Pilot StudyRecruitingPhase 2Université de SherbrookeNCT07104266Written as Celecoxib (Celebrex)
- Celecoxib for Prevention of Progression in Peutz-Jeghers SyndromeRecruitingNot applicableAir Force Military Medical University, ChinaNCT06722534Written as Celecoxib 400mg
- Effects and Mechanisms of Celecoxib on Intracerebral HemorrhageRecruitingPhase 2National Taiwan University HospitalNCT05434065Written as Celecoxib 200mg
- Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous PolyposisRecruitingPhase 3Yonsei UniversityNCT06545526Written as celecoxib monotherapy
- Bioequivalence Study of Generic Celecoxib 200 mg CapsulesNot yet recruitingPhase 1International Bio serviceNCT06337422Written as Celecoxib 200 mg capsule
See all 383 studies that test Celecoxib →
Given beside what is tested · 57 — Celecoxib is usual care or a partner of the new treatment
- Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post ConsolidationRecruitingEarly Phase 1C17 CouncilNCT06942039Written as Celecoxib
- QL1706 Plus Celecoxib in Advanced Esophageal Squamous Cell CarcinomaRecruitingPhase 2Peking University Cancer Hospital & InstituteNCT07049185Written as QL1706 Plus Celecoxib Group
- A Trial in Healthy Participants to Assess Drug Interaction Potential of BGB-43395RecruitingPhase 1BeOne MedicinesNCT07820891Written as Celecoxib
- Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian CancerNot yet recruitingPhase 2Kalinski, Pawel, MD, PhDNCT07634094Written as Celecoxib
- Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS TumorsRecruitingPhase 2Medical University of ViennaNCT01356290Written as Celecoxib
- Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon CancerRecruitingPhase 2The Netherlands Cancer InstituteNCT03026140Written as Celecoxib 200mg
- A Phase I Study of KLA318-2 Nanocrystal InjectionRecruitingPhase 1Hunan Kelun Pharmaceutical Co., Ltd.NCT07171034Written as Celebrex Capsule
- Metformin Safety and Efficacy in Osteoarthritis.RecruitingPhase 3Mostafa BahaaNCT06231758Written as Celecoxib 200mg
- Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal CancerRecruitingPhase 2Zhejiang UniversityNCT05731726Written as Celecoxib
- Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid TumorsRecruitingPhase 2Emory UniversityNCT04469530Written as Celecoxib
- Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal CancerRecruitingPhase 2Fudan UniversityNCT07154316Written as Celecoxib
- Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC)RecruitingPhase 2Fudan UniversityNCT07150949Written as Celecoxib
- Clinical Study Evaluating Safety of Pentoxifylline and Celecoxib in Patients With Grand-Mal Epilepsy Treated by Phenytoin MonotherapyRecruitingPhase 2Mostafa BahaaNCT05637086Written as Celecoxib 200mg
- The Seven Trial: Exploiting the Unfolded Protein ResponseTerminatedPhase 1HonorHealth Research InstituteNCT06076837Written as Celecoxib
- Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal CancerCompletedPhase 1/2University of Southern CaliforniaNCT00159484Written as Celecoxib
- Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural MesotheliomaCompletedPhase 3Ferring Ventures LimitedNCT03710876Written as Celecoxib Oral Product
- Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS TumorsActive, not recruitingPhase 2Emory UniversityNCT02574728Written as Celecoxib
- Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) RegimenCompletedPhase 3Heron TherapeuticsNCT03974932Written as Celecoxib
- Opioid-Free Pain Protocol After Shoulder ArthroplastyActive, not recruitingPhase 4Henry Ford Health SystemNCT05488847Written as Celecoxib
- A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative NeoplasmActive, not recruitingPhase 1AbbVieNCT04041050Written as Celecoxib
Showing 20 of 57.
As the comparator · 53 — what is tested is compared with Celecoxib
- 99Tc-MDP Treatment for Knee OsteoarthritisRecruitingNot applicableXinhua Hospital, Shanghai Jiao Tong University School of MedicineNCT02993029Written as Celecoxib
- INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive DisorderRecruitingPhase 3Universiteit AntwerpenNCT05644301Written as Celecoxib
- Shengyu Decoction and Lijin Manipulation for Knee OA: 3D Gait AnalysisEnrolling by invitationEarly Phase 1Xuhui Central Hospital, ShanghaiNCT06451783Written as Celecoxib capsule
- Efficacy and Mechanism of FSN Treatment for Senile Knee OsteoarthritisNot yet recruitingNot applicableGuangdong Provincial Hospital of Traditional Chinese MedicineNCT06328153Written as Celecoxib
- A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee OsteoarthritisCompletedPhase 1Shandong Suncadia Medicine Co., Ltd.NCT07351968Written as Celecoxib capsule
- Comparison of Efficacy of Minocyclin and Celecoxib as Adjunctive Treatment in Treatment Resistant Cases of Major Depressive DisorderCompletedNot applicableLahore General HospitalNCT07804979Written as Celecoxib
- Evaluation of Clinical Efficacy of Herbal Compound in the Treatment of NSLBPCompletedPhase 4Zhejiang Provincial Tongde HospitalNCT06336993Written as Celecoxib
- Effect of Diacerein vs Celecoxib on Symptoms and Structural Changes in Symptomatic Knee OsteoarthritisCompletedPhase 3TRB Chemedica International SANCT02688400Written as Celecoxib
- Efficacy and Safety of SKCPT in Patients With Knee Osteoarthritis: Phase III Clinical TrialCompletedPhase 3SK Chemicals Co., Ltd.NCT05930080Written as Celebrex
- Different Kinds of Acupuncture Treatment for Knee OsteoarthritisCompletedNot applicableZhejiang Chinese Medical UniversityNCT03563690Written as Celebrex
- Effectiveness of Yunnan Baiyao in Improving Fracture PainStatus unknownNot applicablePeking University Third HospitalNCT05765747Written as Celecoxib 200mg
- Evaluate Efficacy and Safety of X0002 in Treatment of Knee OsteoarthritisCompletedPhase 3Jiangsu XinChen-Techfields Pharma Co., LTD.NCT05324163Written as Celecoxib capsules
- Phase III Study of CG100649 in Osteoarthritis PatientsCompletedPhase 3CrystalGenomics, Inc.NCT01765296Written as Celecoxib
- Study of CG100649 Versus Celecoxib in Osteoarthritis PatientsCompletedPhase 2CrystalGenomics, Inc.NCT01341405Written as Celecoxib
- Safety and Efficacy of Etoricoxib 30 mg Versus Celecoxib 200 mg in Korean Participants With OsteoarthritisCompletedPhase 3Organon and CoNCT01554163Written as Celecoxib 200 mg
- Clinical Trial of YYC301 for Treatment of Osteoarthritis of the KneeCompletedPhase 2Yooyoung Pharmaceutical Co., Ltd.NCT03850587Written as Celecoxib 200mg
- Pharmacokinetics Of Celecoxib Test FormulationsCompletedPhase 1Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00925106Written as Celebrex capsule
- Long Term Safety and Efficacy Study of Tanezumab in Japanese Adult Subjects With Chronic Low Back PainCompletedPhase 3PfizerNCT02725411Written as Celecoxib
- A Study of LY3023703 Testing Pain Relief After Wisdom Teeth RemovalCompletedPhase 2Eli Lilly and CompanyNCT01872910Written as Celecoxib
- A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee PainTerminatedPhase 2Eli Lilly and CompanyNCT02192190Written as Celecoxib
Showing 20 of 53.
What changed recently
From the registry's own updates since Oct 18, 2026.
Started recruiting1
- SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID DysfunctionOct 28, 2026NCT07597902
Newly registered1
- Ivarmacitinib With or Without Celecoxib for Ankylosing SpondylitisOct 26, 2026NCT07894497
Codes
What other systems call Celecoxib · ClinicalTrials.gg INT006520
- MeSH (NLM) D000068579CelecoxibConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) JCX84Q7J1LCELECOXIBConfirmed FDA, NLM, Wikidata
- RxNorm 140587Confirmed FDA, Wikidata
- Wikidata Q408801celecoxibConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1728CelecoxibOne source FDA
- DrugBank DB00482One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000068579 | Celecoxib | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | JCX84Q7J1L | CELECOXIB | Confirmed FDA, NLM, Wikidata |
| RxNorm | 140587 | — | Confirmed FDA, Wikidata |
| Wikidata | Q408801 | celecoxib | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1728 | Celecoxib | One source FDA |
| DrugBank | DB00482 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.